Pathophysiological rationale of the use of microRNA in cardio- and oncological diagnostics (review)

Abstract

Numerous attempts to study and prove the genetic nature of most diseases have led to the discovery of new markers, which are the class of so-called “small ribonucleic acids (RNA)” or microRNA. This review discusses the molecular mechanisms of cardiovascular and tumor diseases involving microRNAs and explores their possible use as diagnostic and therapeutic targets.